Immunotherapy: a promising alternative (IMAGE) Université catholique de Louvain Caption Sophie Lucas, a researcher at the UCLouvain de Duve Institute, studies the immune responses that cancer patients can develop against their own tumour. She is currently testing a new anti-cancer drug that would strengthen such immune responses. Credit Copyright UCLouvain Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.